Showing results (81-90 of 185) with videos related to
Sort By:
Pageof 19
Current Medicinal Chemistry. Anti-Cancer Agents|February 22, 2005
The impact of tumor physiology on camptothecin-based drug developmentDavid J AdamsCurrent Medicinal Chemistry. Anti-Cancer Agents|February 22, 2005
Cisplatin resistance and transcription factorsTakayuki Torigoe, Hiroto Izumi, Hiroshi Ishiguchi, et al.Current Medicinal Chemistry. Anti-Cancer Agents|February 22, 2005
Targeting microtubules for cancer chemotherapyJun Zhou, Paraskevi GiannakakouCurrent Medicinal Chemistry. Anti-Cancer Agents|February 22, 2005
Chemoresistance in non-small cell lung cancerPascal Sève, Charles DumontetCurrent Medicinal Chemistry. Anti-Cancer Agents|July 30, 2004
Lamellarins, from A to Z: a family of anticancer marine pyrrole alkaloidsChristian BaillyCurrent Medicinal Chemistry. Anti-Cancer Agents|July 23, 2003
Hypoxic radiosensitizers and hypoxic cytotoxins in radiation oncologyMartin Weinmann, Stefan Welz, Michael BambergCurrent Medicinal Chemistry. Anti-Cancer Agents|December 8, 2004
Aromatase inhibitors: a new paradigm in breast cancer treatmentJ Narashimamurthy, A Raghu Ram Rao, G Narahari SastryCurrent Medicinal Chemistry. Anti-Cancer Agents|May 12, 2004
Synthetic retinoids and their nuclear receptorsM I DawsonCurrent Medicinal Chemistry. Anti-Cancer Agents|May 12, 2004
On the selectivity of 5-aminolevulinic acid-induced protoporphyrin IX formationSabine Collaud, Asta Juzeniene, Johan Moan, et al.Current Medicinal Chemistry. Anti-Cancer Agents|February 3, 2004
Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulatorsAhmad R SafaPageof 19